---
figid: PMC2494582__nihms55746f1
figtitle: Bypassing vasopressin receptor signaling pathways in nephrogenic diabetes
  insipidus
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC2494582
filename: nihms55746f1.jpg
figlink: /pmc/articles/PMC2494582/figure/F1/
number: F1
caption: This model shows the interactions between the components of some of the major
  pathways that affect AQP2, and summarizes most of the points outlined in this review.
  The canonical V2R signaling pathway is depicted, with VP stimulation of V2R leading
  to the phosphorylation of AQP2 by PKA and subsequently altering the balance between
  exocytosis and endocytosis, leading to AQP2 accumulation at the apical plasma membrane.
  Also shown are the NO-cGMP pathway and the PGE2 receptor EP3 that can also positively
  and negatively modulate AQP2 trafficking respectively, as well as factors that affect
  AQP2 abundance and the elements and transcription factors that mediate this regulation.
  (activator protein-1 element (AP1), adenylate cyclase (AC), aquaporin-2 (AQP2),
  cAMP response element (CRE), CRE binding protein (CREB), cyclooxygenase (COX), G-protein
  i α subunit (Giα), G-protein s α subunit (Gsα), guanylate cyclase (GC), heat-shock
  protein of 70kDa (hsp70), myelin and lymphocyte-associated protein (MAL), nitric
  oxide (NO), nitric oxide synthase (NOS), nuclear factor of activated T-cells c (NFATc),
  phosphodiesterase (PDE), prostaglandin E2 (PGE2), prostaglandin receptor (EP3),
  protein kinase G (PKG), protein kinse A (PKA), Rho family small GTPase (Rho), tonicity
  response element (TonE), TonE binding protein (TonEBP), vasopressin (VP), vasopressin
  receptor type-2 (V2R))
papertitle: Bypassing vasopressin receptor signaling pathways in nephrogenic diabetes
  insipidus.
reftext: Richard Bouley, et al. Semin Nephrol. ;28(3):266-278.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9226442
figid_alias: PMC2494582__F1
figtype: Figure
redirect_from: /figures/PMC2494582__F1
ndex: 0e37de76-df0e-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2494582__nihms55746f1.html
  '@type': Dataset
  description: This model shows the interactions between the components of some of
    the major pathways that affect AQP2, and summarizes most of the points outlined
    in this review. The canonical V2R signaling pathway is depicted, with VP stimulation
    of V2R leading to the phosphorylation of AQP2 by PKA and subsequently altering
    the balance between exocytosis and endocytosis, leading to AQP2 accumulation at
    the apical plasma membrane. Also shown are the NO-cGMP pathway and the PGE2 receptor
    EP3 that can also positively and negatively modulate AQP2 trafficking respectively,
    as well as factors that affect AQP2 abundance and the elements and transcription
    factors that mediate this regulation. (activator protein-1 element (AP1), adenylate
    cyclase (AC), aquaporin-2 (AQP2), cAMP response element (CRE), CRE binding protein
    (CREB), cyclooxygenase (COX), G-protein i α subunit (Giα), G-protein s α subunit
    (Gsα), guanylate cyclase (GC), heat-shock protein of 70kDa (hsp70), myelin and
    lymphocyte-associated protein (MAL), nitric oxide (NO), nitric oxide synthase
    (NOS), nuclear factor of activated T-cells c (NFATc), phosphodiesterase (PDE),
    prostaglandin E2 (PGE2), prostaglandin receptor (EP3), protein kinase G (PKG),
    protein kinse A (PKA), Rho family small GTPase (Rho), tonicity response element
    (TonE), TonE binding protein (TonEBP), vasopressin (VP), vasopressin receptor
    type-2 (V2R))
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NOS1
  - NOS2
  - NOS3
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - MTG1
  - NFATC1
  - NFAT5
  - ALDH7A1
  - PDE2A
  - PDE9A
  - PDE10A
  - PDE11A
  - PDE1A
  - PDE1B
  - PDE1C
  - PDE3A
  - PDE3B
  - PDE4A
  - PDE4B
  - PDE4C
  - PDE4D
  - PDE6A
  - PDE6B
  - PDE6C
  - PDE7A
  - PDE7B
  - PDE8A
  - PDE8B
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - PRKG1
  - GC
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - FOSL1
  - FOSL2
  - AQP2
  - ATP8A2
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - PTGER3
  - DOCK11
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - AVPR2
  - COX8A
  - CPOX
  - COX5A
  - COX5B
  - COX6C
  - COX7C
  - .na.character
  - COX4I1
  - COX4I2
  - COX6A1
  - COX6A2
  - COX6B1
  - COX6B2
  - COX7A1
  - COX7A2
  - COX7B
  - COX7B2
  - COX8C
  - Nos
  - nos
  - Act5C
  - Act42A
  - Act57B
  - Act79B
  - Act88F
  - Act87E
  - rho
  - Bx
  - Rho1
  - Lcp65Ab1
  - dnc
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Pkg21D
  - for
  - mirr
  - AP-1gamma
  - Jra
  - kay
  - ATPsynbeta
  - Atpalpha
  - CrebB
  - CrebA
  - tRNA:Thr-TGT-1-1
  - tRNA:Thr-TGT-2-1
  - tRNA:Thr-TGT-2-2
  - tRNA:Thr-TGT-2-5
  - tRNA:Thr-TGT-2-4
  - tRNA:Thr-TGT-2-3
  - tRNA:Thr-CGT-1-2
  - tRNA:Thr-CGT-1-3
  - tRNA:Thr-CGT-1-1
  - ac
  - COX4
  - PGE
---
